Transcript
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
OXYNTOMODULINDiabetes
AUR A KINASE INHIBITOR Cancer
MIRIKIZUMABCrohn’s Disease
BARICITINIB Systemic Lupus Erythematosus
MEVIDALENSymptomatic LBD
TIRZEPATIDEDiabetes
EMPAGLIFLOZIN*Heart Failure pEF
TANEZUMAB*Osteoarthritis Pain
SOLANEZUMABPreclinical AD
MIRIKIZUMABUlcerative Colitis
BTLA MAB AGONISTImmunology
CD200R MAB AGONIST Immunology
O-GLCNACASE INHAlzheimer’s
GGG TRI-AGONISTDiabetes
CONNECTED CARE PREFILLED INSULIN PEN Diabetes
GLP-1R NPADiabetes
SERDCancer
TIRZEPATIDEObesity
LEBRIKIZUMABAtopic Dermatitis
SELPERCATINIB1L Med Thyroid Cancer
GIP/GLP COAGONIST PEPTIDE Diabetes
N3PG Ab MAB Alzheimer’s
NRG4 AGONISTHeart Failure
KHK INHIBITORDiabetes / NASH
LP(a) INHIBITORCVD
IDH1 INHIBITOR Cancer
EMPAGLIFLOZIN*Heart Failure rEF
ABEMACICLIBAdjuvant Breast Cancer
TRPA1 ANTAGONIST Pain
GRN GENE THERAPYFrontotemporal Dementia
GBA1 GENE THERAPYParkinson’s Disease
ANGPTL3 siRNA CVD
GIPR AGONIST LA Diabetes
IL-17A SMALL MOLINHIBITOR Immunology
KHK INHIBITOR IIDiabetes / NASH
P2X7 INHIBITORPain
NOT DISCLOSEDDiabetes
PYY ANALOGDiabetes
RIPK1 INHIBITORImmunology
GIP/GLP COAGONIST PEPTIDE II Diabetes
ANGPTL3/8 MABCVD
RELAXIN-LAHeart Failure
BASAL INSULIN-FCDiabetes
AUTOMATED INSULIN DELIVERY SYS Diabetes
CXCR1/2L MABHidradenitis Suppurativa
EPIREG/TGFa MABChronic Pain
IL-2 CONJUGATESystemic Lupus Erythematosus
PACAP38 MABMigraine
SSTR4 AGONISTPain
TIRZEPATIDENASH
ABEMACICLIBProstate Cancer
ZAGOTENEMAB Alzheimer’s
DONANEMABEarly Alzheimer’s
EMPAGLIFLOZIN*Post MI
MIRIKIZUMABPsoriasis
BARICITINIBAlopecia Areata
TANEZUMAB*Cancer Pain
TIRZEPATIDECV Outcomes
SELPERCATINIB1L NSCLC
EMPAGLIFLOZIN*Chronic Kidney Disease
VIR-7831 +BAMLANIVIMAB COVID-19
PIRTOBRUTINIB(LOXO-305)B-Cell Malignancies
PIRTOBRUTINIB(LOXO-305)R/R CLL monotherapy
CD73 INHIBITOR Cancer
LY-CoV1404 MABCOVID-19
NME
NILEX
*
MOVEMENT SINCEJanuary 26, 2021
ADDITION or
MILESTONE ACHIEVED
REMOVAL
Commercial
Collaboration
^ Emergency Use Authorization has been granted in
the US and other countries
IL-2 CONJUGATEUlcerative Colitis
PD-1 MAB AGONISTRheumatoid Arthritis
BARICITINIB^COVID-19
BAMLANIVIMAB & ETESEVIMAB^COVID-19
New since last update
✓✓
✓
✓
✓
✓
✓
✓
✓
✓
✓
✓✓
✓
✓
✓✓
✓
▪
▪
▪
▪
▪
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
>
>
>
>
>
<
<
>
>
top related